Sign up to save tools and stay up to date with the latest in AI
bg
bg
2

InnovationRx: Making The Pharma Supply Chain More Resilient

Sep 21, 2023 - forbes.com
Christina Smolke, CEO of synthetic biology startup Antheia, is producing key ingredients for medicines using yeast fermentation, which can produce over 100 million doses of medication in five days. This method significantly reduces the time and space required for producing these ingredients compared to traditional methods. Meanwhile, bankrupt digital health company Babylon sold its UK telemedicine assets to eMed for $620,000, despite owing its main lender AlbaCore $380.5 million in loans.

In other news, several healthcare startups have raised significant funding, including Belgium-based Awell, which raised $5 million for its clinical workflow software, and Generate:Biomedicines, which raised $273 million for its protein-based drug development. The FDA also granted 510(k) clearance to fertility tracking app Natural Cycles for integration with the Apple Watch. Finally, Vertex Pharmaceuticals researchers were honored with the 2024 Breakthrough Prize for their work in treating cystic fibrosis.

Key takeaways:

  • Christina Smolke, CEO of Antheia, is producing key ingredients for medicines using yeast fermentation, which can produce over 100 million doses of medication in five days.
  • Bankrupt digital health company Babylon has sold its U.K. telemedicine assets to eMed for $620,000. Babylon owes its main lender AlbaCore a combined $380.5 million in loans.
  • Several healthcare startups have raised significant funding, including Awell ($5 million), Generate:Biomedicines ($273 million), and Corti ($60 million).
  • Researchers at Vertex Pharmaceuticals were honored with the 2024 Breakthrough Prize for their work in the treatment of cystic fibrosis.
View Full Article

Comments (0)

Be the first to comment!